Biotech Growth N V - Apr 11, 2022 Form 3 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Role: 10%+ Owner
Signature: /s/ Ivo Betschart
Stock symbol: BDTX
Transactions as of: Apr 11, 2022
Transactions value $: $0
Form type: 3
Date filed: 4/13/2022, 04:22 PM
Previous filing: Aug 20, 2021
Next filing: Apr 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BDTX	Common Stock						3.74M	Apr 11, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Black Diamond Therapeutics, Inc. held directly or indirectly by Biotech Growth N.V. The Form 3 is jointly filed by BB Biotech AG and Biotech Growth N.V.